U.S. biotechs should protect employee access to abortion, Hastings says

In the wake of a leaked draft Supreme Court ruling overturning abortion rights, U.S. biopharma leaders should take steps to ensure that their employees have access to reproductive health technologies, Paul Hastings, president and CEO of Nkarta Inc. (NASDAQ:NKTX), told BioCentury.

The leaked document, which Supreme Court Chief Justice John Roberts has confirmed is authentic, “opened a window into a bleak, regressive future for women’s health and individual freedoms in states across our country,” Hastings said. ...